CIMDX | JVMCX | CIMDX / JVMCX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 8 years | 14 years | - |
Gain YTD | 0.752 | 1.937 | 39% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 10000 | 1000 | 1,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 785M | 22.5B | 3% |
Annual Yield % from dividends | 0.58 | 0.01 | 4,073% |
Returns for 1 year | 4.33 | -3.41 | -127% |
Returns for 3 years | 11.75 | 0.68 | 1,730% |
Returns for 5 years | 32.82 | 19.69 | 167% |
Returns for 10 years | N/A | 25.70 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
EMPTX | 8.15 | 0.08 | +0.99% |
UBS Emerging Markets Equity Opp P2 | |||
SPRDX | 68.93 | 0.02 | +0.03% |
Sprucegrove International Eq Adv | |||
CNPCX | 60.28 | -0.73 | -1.20% |
American Funds New Perspective 529C | |||
CSHNX | 11.80 | -0.21 | -1.75% |
NYLI Cushing® MLP Premier Investor Class | |||
BKTSX | 27.43 | -0.52 | -1.86% |
iShares Total US Stock Market Idx K |